DaeYong Lee

1.6k total citations · 1 hit paper
33 papers, 1.0k citations indexed

About

DaeYong Lee is a scholar working on Molecular Biology, Immunology and Biomedical Engineering. According to data from OpenAlex, DaeYong Lee has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Immunology and 11 papers in Biomedical Engineering. Recurrent topics in DaeYong Lee's work include Nanoplatforms for cancer theranostics (11 papers), RNA Interference and Gene Delivery (9 papers) and Immunotherapy and Immune Responses (6 papers). DaeYong Lee is often cited by papers focused on Nanoplatforms for cancer theranostics (11 papers), RNA Interference and Gene Delivery (9 papers) and Immunotherapy and Immune Responses (6 papers). DaeYong Lee collaborates with scholars based in South Korea, United States and China. DaeYong Lee's co-authors include Yeu‐Chun Kim, Jisang Yoo, Betty Y.S. Kim, Wen Jiang, Kristin Huntoon, Ilkoo Noh, N. Sanoj Rejinold, Chan‐Uk Jeong, Yifan Wang and Sangyong Jon and has published in prestigious journals such as Advanced Materials, Nature Nanotechnology and Biomaterials.

In The Last Decade

DaeYong Lee

33 papers receiving 1.0k citations

Hit Papers

Cancer immunotherapy based on image-guided STING activati... 2022 2026 2023 2024 2022 50 100 150

Peers

DaeYong Lee
Yunkun Li China
Joseph Hardie United States
Jiayan Wu China
Xia Dong China
DaeYong Lee
Citations per year, relative to DaeYong Lee DaeYong Lee (= 1×) peers Huapan Fang

Countries citing papers authored by DaeYong Lee

Since Specialization
Citations

This map shows the geographic impact of DaeYong Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DaeYong Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DaeYong Lee more than expected).

Fields of papers citing papers by DaeYong Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DaeYong Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DaeYong Lee. The network helps show where DaeYong Lee may publish in the future.

Co-authorship network of co-authors of DaeYong Lee

This figure shows the co-authorship network connecting the top 25 collaborators of DaeYong Lee. A scholar is included among the top collaborators of DaeYong Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DaeYong Lee. DaeYong Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grippin, Adam, DaeYong Lee, Eileen E. Parkes, Wen Jiang, & Betty Y.S. Kim. (2025). Nanotechnology for immuno-oncology. Nature Cancer. 6(8). 1311–1325. 3 indexed citations
2.
Schrank, Benjamin R., Yifan Wang, DaeYong Lee, et al.. (2025). An antibody–toxin conjugate targeting CD47 linked to the bacterial toxin listeriolysin O for cancer immunotherapy. Nature Cancer. 6(3). 511–527. 9 indexed citations
3.
Lee, DaeYong, et al.. (2024). Engineering the physical characteristics of biomaterials for innate immune-mediated cancer immunotherapy. Journal of Controlled Release. 378. 814–830. 2 indexed citations
4.
Wang, Yifan, Zhenyu Xiao, Zikai Wang, et al.. (2024). Multi-omics approaches to decipher the interactions of nanoparticles and biological systems. Nature Reviews Bioengineering. 3(4). 333–348. 21 indexed citations
5.
Huntoon, Kristin, et al.. (2023). Targeting phagocytosis to enhance antitumor immunity. Trends in cancer. 9(8). 650–665. 9 indexed citations
6.
Li, Xuefeng, Kristin Huntoon, Yifan Wang, et al.. (2023). Radiation Synergizes with IL2/IL15 Stimulation to Enhance Innate Immune Activation and Antitumor Immunity. Molecular Cancer Therapeutics. 23(3). 330–342. 2 indexed citations
7.
Lee, DaeYong, Kristin Huntoon, Jacques Lux, Betty Y.S. Kim, & Wen Jiang. (2023). Engineering nanomaterial physical characteristics for cancer immunotherapy. Nature Reviews Bioengineering. 1(7). 499–517. 45 indexed citations
8.
Huntoon, Kristin, DaeYong Lee, Yifei Lü, et al.. (2023). 467 Stimulator of Interferon Genes Protein (STING) Agonist Incited Sustained Antitumor Immunity in Murine Models of Glioblastoma. Neurosurgery. 69(Supplement_1). 98–98. 1 indexed citations
9.
Li, Xuefeng, Yifan Wang, Kristin Huntoon, et al.. (2022). Cancer immunotherapy based on image-guided STING activation by nucleotide nanocomplex-decorated ultrasound microbubbles. Nature Nanotechnology. 17(8). 891–899. 151 indexed citations breakdown →
10.
Lü, Yifei, Kristin Huntoon, DaeYong Lee, et al.. (2022). Immunological conversion of solid tumours using a bispecific nanobioconjugate for cancer immunotherapy. Nature Nanotechnology. 17(12). 1332–1341. 48 indexed citations
11.
Jeong, Seong Dong, Bo‐Kyeong Jung, DaeYong Lee, et al.. (2022). Enhanced Immunogenic Cell Death by Apoptosis/Ferroptosis Hybrid Pathway Potentiates PD-L1 Blockade Cancer Immunotherapy. ACS Biomaterials Science & Engineering. 8(12). 5188–5198. 33 indexed citations
13.
Jeong, Seong Dong, Bo‐Kyeong Jung, Hyo Min Ahn, et al.. (2021). Immunogenic Cell Death Inducing Fluorinated Mitochondria‐Disrupting Helical Polypeptide Synergizes with PD‐L1 Immune Checkpoint Blockade. Advanced Science. 8(7). 2001308–2001308. 69 indexed citations
14.
Noh, Ilkoo, Jeesu Kim, DaeYong Lee, et al.. (2020). Structure-inherent near-infrared bilayer nanovesicles for use as photoacoustic image-guided chemo-thermotherapy. Journal of Controlled Release. 320. 283–292. 18 indexed citations
15.
Lee, DaeYong, et al.. (2019). Development of apoptosis-inducing polypeptide via simultaneous mitochondrial membrane disruption and Ca2+ delivery. Biomaterials. 197. 51–59. 18 indexed citations
16.
Lee, DaeYong, Ilkoo Noh, Jisang Yoo, N. Sanoj Rejinold, & Yeu‐Chun Kim. (2017). pH-controllable cell-penetrating polypeptide that exhibits cancer targeting. Acta Biomaterialia. 57. 187–196. 23 indexed citations
17.
Yoo, Jisang, N. Sanoj Rejinold, DaeYong Lee, Sangyong Jon, & Yeu‐Chun Kim. (2017). Protease-activatable cell-penetrating peptide possessing ROS-triggered phase transition for enhanced cancer therapy. Journal of Controlled Release. 264. 89–101. 86 indexed citations
18.
Yoo, Jisang, DaeYong Lee, Vipul Gujrati, et al.. (2016). Bioreducible branched poly(modified nona-arginine) cell-penetrating peptide as a novel gene delivery platform. Journal of Controlled Release. 246. 142–154. 64 indexed citations
19.
Jeong, Chan‐Uk, Jisang Yoo, DaeYong Lee, & Yeu‐Chun Kim. (2016). A branched TAT cell-penetrating peptide as a novel delivery carrier for the efficient gene transfection. Biomaterials Research. 20(1). 28–28. 29 indexed citations
20.
Lee, DaeYong, et al.. (2016). Polypeptide-based polyelectrolyte complexes overcoming the biological barriers of oral insulin delivery. Journal of Industrial and Engineering Chemistry. 48. 79–87. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026